Physician profile
Gary Levy
NPI 1750725206
$14,875.35
in general payments reported to CMS, 2019-2025
8 companies · $354 in 2025
The $354 reported for 2025 was more than what 82% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $1,765 · 2022: $12.21 · 2023: $12.84 · 2024: $80.28 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $447.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $14,398.19 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $137.00 | 2019-2025 | Menopur |
| Coopersurgical, INC. | $115.17 | 2025 | Origio Sequential Fert |
| Emd Serono, INC. | $72.05 | 2025 | |
| Organon LLC | $66.35 | 2024-2025 | Follistim Aq, Ganirelix Acetate, Pregnyl |
| Hologic Sales and Service, LLC | $61.54 | 2025 | Myosure Tissue Removal Device |
| Medtronic, INC. | $12.84 | 2023 | Valleylab Ft10 |
| Myovant Sciences INC. | $12.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.